CS MEDICA A/S announced that they obtained the company registration number: Owner Operator Number: 10089433 (Medical Devices) & FEI number: 3030062474 (Cosmetic), at the U.S. Food and Drug Administration (FDA) and has registered Eight innovative products for sale in the United States. This milestone approval includes a range of VET and cosmetic products and three medical devices designed for over-the-counter pain relief. The list of approved products is; Medical Devices: Pain Patch; Nasal Night Spray; Wound Gel; cosmetic: Anti-Hair loss serum; Skin Relief Lotion;et products: Pain Patch; Pain & Arthritis Gel; Wound Gel.

Each of these products features Cannabis Sativa L as part of the synergy of the ingredients, reflecting commitment to harnessing the potentials of cannabis. The [CD1]listing of these products in the FDA database, marks a significant step in journey, especially considering the U.S. is one of the most developed markets for cannabis-infused products. The medical devices and cosmetic products will be live on Amazon in January 2024 to advance the company's go-to-market plans for the U.S. territory.

New distribution partners are expected to be onboarded during the first quarter of 2024. This strategic move will enable the company to reach a wider audience, ensuring the products are easily accessible to consumers across the United States.